Video & Transcript Research : 'FDA'
Page 39 of 62
CA
California 2025-2026 Regular Session
Assembly Environmental Safety Committee and Toxic Materials Committee Jul 15th, 2025
Environmental Safety and Toxic Materials
CA
California 2025-2026 Regular Session
Assembly Select Committee On Alternative Protein Innovation Jun 25th, 2025
Transcript Highlights:
- And I believe it was after one of the approvals, FDA maybe, and you're waiting for USDA still at that
Summary:
The Select Committee on Alternative Protein Innovation held its first informational hearing to examine the state of alternative protein research, industry growth, and policy needs in California. The chair opened by noting California’s $5 million public investment in UC research in 2022 and framed the hearing around three panels: the climate, environmental, and security potential of alternative proteins; industry scaling and commercialization; and university-led research and workforce development. Members emphasized that the committee will continue with site visits and additional hearings across the state.
The first panel focused on the case for alternative proteins as a climate, land, water, biodiversity, and food-security solution. Shana Fertig of the Good Food Institute argued that plant-based, fermentation-derived, and cultivated proteins can reduce greenhouse gas emissions, land use, and water use while helping California meet its climate and conservation goals. Zane Swanson of CSIS added that alternative proteins could reduce risks tied to zoonotic disease, antimicrobial resistance, supply-chain disruption, and broader national security concerns. In questions, members discussed the role of pharmaceuticals in animal agriculture and how alternative proteins might complement, rather than replace, traditional farming by creating new markets for California crops and helping farmers diversify.
The second panel featured industry leaders Ethan Brown of Beyond Meat, Myra Passick of Upside Foods, and Arye Elfenbein of Wildtype. Brown highlighted plant-based meat’s health and climate benefits, criticized misinformation campaigns against the sector, and urged better labeling, reduced subsidies for factory farming, and more plant-based food in public institutions. Passick described cultivated meat as a scalable food-production technology, said Upside Foods has already produced millions of pounds annually at its Emeryville facility, and asked for grants, low-interest loans, and possible participation in cap-and-trade or similar revenue programs. Elfenbein described cultivated seafood as a way to address overfishing, contamination, traceability problems, and the heavy import dependence of the U.S. seafood supply, while also noting conservation benefits and the need for California to remain a hub for the industry.
The final panel centered on research and workforce development. UCLA’s Amy Rowat described state-funded work on technical bottlenecks such as growing fat cells and creating edible scaffolds, along with a Future Food Fellows program that trains students across science, engineering, law, and policy. UC Santa Cruz economist Galina Hale argued that alternative proteins are necessary to meet future protein demand while reducing food-system emissions, and said California must support the sector through grants, loans, procurement, and research centers to avoid losing leadership to other states and countries. The hearing ended with the chair thanking the witnesses, noting that all materials would be posted online, and saying the committee would continue building policy and budget proposals to support the sector.
NM
New Mexico 2025 Regular Session
IC - Radioactive and Hazardous Materials May 29th, 2025
Radioactive & Hazardous Materials Committee
Transcript Highlights:
- workers in the agencies that I deal with, the EPA, Department of Energy, NNSA, Department of Labor, FDA
TX
Transcript Highlights:
- Looking at, as you know, how the FDA approves certain chemicals in our food and different things, the
Bills:
SB731, SB801, SB867, SB2082, SB2717, SB2919, HB4, HB26, HB103, HB108, HB117, HB126, HB144, HB145, HB186, HB201, HB223, HB229, HB272, HB493, HB521, HB551, HB621, HB700, HB748, HB1106, HB1234, HB1403, HB1500, HB1661, HB2017, HB2026, HB2035, HB2038, HB2073, HB2080, HB2221, HB2253, HB2294, HB2306, HB2313, HB2427, HB2512, HB2516, HB2593, HB2674, HB2761, HB2818, HB2820, HB2844, HB2851, HB2885, HB3010, HB3016, HB3053, HB3057, HB3133, HB3151, HB3159, HB3180, HB3181, HB3225, HB3234, HB3250, HB3254, HB3284, HB3333, HB3512, HB3556, HB3595, HB3689, HB3711, HB3732, HB3749, HB3812, HB3833, HB3866, HB3928, HB3940, HB3966, HB4063, HB4112, HB4157, HB4264, HB4281, HB4384, HB4454, HB4486, HB4488, HB4520, HB4530, HB4666, HB4690, HB4743, HB4749, HB4751, HB4795, HB4848, HB4903, HB5081, HB5115, HB5138, HB5149, HB5154, HB5247, HB5308, HB5394, HB5436, HB5659, HB5671, HB5674, HB5680, HB5696, HCR40, HCR108, HCR118, SJR5, SJR59, SB4, SB8, SB9, SB10, SB12, SB22, SB23, SB25, SB27, SB34, SB36, SB37, SB38, SB40, SB261, SB650, SB777, SB924, SB1188, SB1318, SB1333, SB1398, SB1448, SB1566, SB1621, SB1723, SB1862, SB2405, SB2406, SB2407, SB3070, SB1, SB17, SB21, SB260, SB379, SB509, SB1405, SB1506, SB1637, SB1833, SB2155, SB2308, HB300, HB2525, SJR36, SJR50, SJR63, SCR12, SCR39, SB2023, SB62, SB666, SB847, SB284, SB854, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1122, SB731, SB397, SB508, SB1436, SB287, SB1882, SB393, SB1791, SB209, SB2429, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB1200, SB1845, SB2458, SB801, SB3014, SB3013, SB758, SB2797, SB2076, SB2876, SB1640, SB1449, SB1181, SB1234, SB2926, SB2841, SB1528, SB1854, SB317, SB1250, SB2082, SB1237, SB2819, SB629, SB2608, SB1602, SB2009, SB867, SB640, SB1698, SB2680, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB2334, SB1367, SB2044, SB2363, SB2565, SB1888, SB3036, SB3057, SB3043, SB3063, SB3035, SB203, SB2688, SB2522, SB2459, SB2655, SB2251, SB1884, SB2928, SB2566, SB2549, SB2553, SB2919, SB1944, SB1232, SB1798, SB2603, SB2607, SB2683, SB1319, SB3045, SB3071, HJR7, HB2674, HB3556, HB26, HB4384, HB748, HB5652, HB3395, HB2516, HB180, HB1306, HB3966, HB4112, HB322, HB126, HB5650, HB4894, HB1629, HB5698, HB3171, HB2694, HB5664, HB4751, HB4690, HB4464, HB4063, HB3623, HB3016, HB2520, HB2221, HB2213, HB700, HB252, HB146, HB5596, HB3619, HB5320, HB5651, HB5670, HB5665, HB5437, HB5679, HB5699, HB5661, HB5662, HB5654, HB5672, HB5656, HB4743, HB4666, HB3812, HB3595, HB3057, HB2035, HB721, HB346, HB2512, HB5695, HB5694, HB5671, HB5674, HB2038, HB3185, HB2761, HB2593, HB2348, HB2073, HB1871, HB108, HB2306, HB2017, HB1135, HB144, HB3689, HB5308, HB101, HB5666, HB5677, HB5682, HB5680, HB5658, HB5696, HB4144, HB3159, HB3254, HB3866, HB3010, HB4520, HB3642, HB3928, HB3815, HB2686, HB2012, HB1960, HB227, HB654, HB1690, HB2128, HB4158, HB4530, HB4630, HB5659, HB1523, HB2078, HB2427, HB145, HB1973, HB3333, HB3697, HB3546, HB3225, HB3181, HB3133, HB3053, HB2885, HB2820, HB2294, HB2253, HB1661, HB1506, HB1234, HB640, HB621, HB551, HB521, HB493, HB272, HB229, HB223, HB201, HB186, HB119, HB2080, HB2818, HB5394, HB4795, HB4466, HB4454, HB3940, HB3749, HB3151, HB3284, HB1403, HB1106, HB2844, HB2851, HB1500, HB4488, HB4264, HB4, HB4170, HB3909, HB4081, HB4145, HB4157, HB4281, HB4285, HB4463, HB4749, HB4995, HB5081, HB5115, HB5138, HB5624, HB1449, HB3711, HB2598, HB3629, HB4361, HB824, HB1868, HB4848, HB2243, HB40, HB117, HB2313, HB3686, HB500, HB3793, HB112, HB104, HB1056, HB42, HB4486, HB3000, HB100, HB2240, HB718, HB27, HB4904, HB4202, HB2853, HB5129, HB5093, HB4765, HB4748, HB4559, HB4350, HB4214, HB3388, HB3112, HB5196, HB4211, HB3516, HB3092, HB4233, HB4687, HB705, HB1094, HB2037, HB3005, HB3848, HB1105, HB121, HB3372, HB367, HB783, HB3336, HB3441, HB4449, HB5616, HB2407, HB2854, HB3425, HB5294, HB1178, HB4623, HB14, HB3963, HB1211, HB5646, HB5629, HB3783, HB4236, HB46, HB4638, HB1052, HB4070, HB5509, HB5435, HB4134, HB3923, HB3520, HB3320, HB2517, HB2488, HB5663, HB2731, HB3073, HB2655, HB2399, HB541, HB4099, HB111, HB1532, HB3483, HB2963, HB4580, HB3748, HB713, HB632, HB426, HB4730, HCR141, HCR118, HCR40, HCR59, HCR76, HCR108, HB26, HB108, HB144, HB145, HB201, HB272, HB493, HB551, HB621, HB700, HB1500, HB1661, HB2017, HB2038, HB2073, HB2080, HB2221, HB2253, HB2294, HB2306, HB2313, HB2427, HB2516, HB2593, HB2761, HB2818, HB2844, HB2851, HB2885, HB3010, HB3016, HB3133, HB3151, HB3159, HB3254, HB3284, HB3595, HB3689, HB3711, HB3866, HB3928, HB3940, HB3966, HB4063, HB4112, HB4264, HB4281, HB4384, HB4454, HB4486, HB4488, HB4520, HB4530, HB4666, HB4743, HB4749, HB4751, HB5081, HB5308, HB5394, HB5659, HB5671, HB5680, HB5696, HB2674, HB3556, HB223, HB1403, HB3053, HB5115, HCR108, HCR118, SB20, SB33, SB75, SB213, SB269, SB458, SB528, SB647, SB648, SB681, SB740, SB840, SB843, SB1061, SB1120, SB1121, SB1150, SB1202, SB1253, SB1423, SB1535, SB1574, SB1709, SB1789, SB2037, SB2078, SB2268, SB2544, SB2570, SB1198, SB2601, SB2778
Keywords:
SB 731, Texas, Texas Department of Housing and Community Affairs, TDHCA, low-income housing tax credits, LIHTC, affordable housing, senior housing, 55 and older, elderly housing, multifamily housing, apartment buildings, high-rise, four-story building, water pressure booster, water pressure system, emergency water supply, building safety, housing development regulations, Government Code Chapter 2306
TX
Texas 89th Regular
Water, Agriculture, and Rural Affairs May 19th, 2025
Water, Agriculture and Rural Affairs
Transcript Highlights:
- In 2020, the Department of State Health Services adopted FDA guidelines that considered the extraction
Keywords:
agriculture, finance, young farmers, financial assistance, pest control, honey production, beekeeping, food safety, local regulation, bovine producers, dairy farms, permits, bovine tuberculosis, public health, wildlife management, disease prevention, alert system, Texas A&M, white-tailed deer, public safety
Summary:
The Senate Committee on Water, Agriculture, and Rural Affairs met with only four members initially present, so quorum was not established until later in the hearing. The committee heard several agriculture-, wildlife-, and food-labeling-related bills, including HB 3479 on expanding the Rio Grande vegetative management program beyond carrizo cane to other noxious vegetation, SB 823 on shrimp origin labeling and restrictions on misrepresenting imported shrimp as Texas or Gulf shrimp, HB 3088 on giving Texas Parks and Wildlife more flexibility to procure resale goods for park gift shops, HB 1275 on permits for non-bovine dairy farms in certain TB-affected areas, HB 519 on honey production and packaging rules, HB 609 on cleaning oyster cages in-bay with bay water only, HB 1592 on a voluntary AgriLife pest and disease alert system, HB 2842 on targeted urban deer depredation permits, and HB 4163 on limiting city requirements that agricultural operators maintain roadside rights-of-way. Testimony generally came from industry groups, agency resource witnesses, and affected producers, with most witnesses supporting the bills and several bills drawing questions about enforcement, labeling responsibility, and the scope of local authority.
The most extensive discussion centered on SB 823, where Vice Chair Hancock and others questioned why wholesalers would be covered if they cannot relabel products. The bill author and restaurant association witness said the measure was intended to improve transparency and allow enforcement against intentional mislabeling, while preserving a good-faith defense and clarifying that the bill does not create a private cause of action. HB 519 also drew supportive testimony from beekeepers and a family farm, who argued that current rules treat honey extraction and bottling too much like food manufacturing and burden small operations. HB 609 was presented as a way to save time and resources for cultivated oyster mariculture by allowing cage cleaning in the bay without soaps or chemicals, and HB 1592 was described as a voluntary opt-in alert system for pests and diseases coordinated through AgriLife and other state agencies.
HB 43 generated the most detailed policy debate. The bill would restructure and expand the Texas Agricultural Finance Authority, update grant and loan programs, and create a pest and disease control depredation program. The committee substitute reduced some funding caps, changed references from predators to depredating animals, and made the financial provisions contingent on appropriations. Supporters from Texas Farm Bureau, cotton growers, grain and feed interests, and young farmers described severe drought, inflation, land loss, rising input costs, and shrinking infrastructure as major threats to agriculture, while one witness urged preserving priority for young farmers. After testimony, the committee adopted the committee substitute and reported HB 43 favorably. The committee also voted HB 519, HB 609, HB 1275, HB 1592, HB 3088, HB 3479, HB 2842, and HB 4163 favorably, with several recommended for the local and uncontested calendar. SB 823 was reported from committee on a 6-2 vote after adoption of the committee substitute. The meeting ended with notice that the committee would tentatively reconvene Friday morning and then recessed subject to the chair's call.
CA
California 2025-2026 Regular Session
Assembly Appropriations Committee May 14th, 2025
Transcript Highlights:
- California, specifically mifepristone, a common and safe medication abortion drug first approved by the FDA
Summary:
The Assembly Appropriations Committee met on May 14, 2025, for a regular order hearing with a large consent calendar and many individual bill presentations. The committee first approved numerous bills on consent, then heard a series of measures spanning reproductive health, child care eligibility, transportation, mental health diversion, county recorder fees, groundwater management, election deadlines, parking enforcement, consumer protections, housing, immigrant and student protections, and utility/CPUC oversight. Several bills were taken up only for presentation because they were on suspense, including ACA 4 on long-term housing funding, and the committee later approved a very large suspense calendar as a whole.
Among the bills discussed, AB 260 would protect medication abortion access and providers; AB 904 would clarify child care subsidy eligibility during family leave or job search; AB 1014 would give Caltrans more flexibility on speed limits in rural highway segments; AB 46 would clarify judicial discretion in mental health diversion; AB 1413 and AB 929 addressed groundwater adjudication and SGMA-related protections for small community water systems and wetlands; AB 930 would count vote-by-mail ballots postmarked by Election Day and received within seven days; AB 1022 would end towing solely for unpaid parking tickets; AB 290 and AB 302 dealt with automatic payments for the California Fair Plan and medical data protections; AB 1303 would remove the need for a Social Security number for California Lifeline eligibility; and several housing bills, including AB 920, AB 956, AB 1470, AB 893, and AB 1021, sought to streamline approvals or expand housing options. AB 1318 and AB 49 focused on immigrant-serving nonprofits and keeping immigration enforcement out of schools, while AB 1532 extended telecommunications and transportation access programs and added CPUC accountability measures.
Testimony was generally supportive for the bills heard, with authors and sponsors emphasizing low or absorbable fiscal impacts, consumer protection, housing production, public safety, and protections for vulnerable communities. Opposition appeared on a few measures, including concerns about ADUs, towing authority, charter school-related issues, and the scale of proposed housing funding in ACA 4. Several members also commented in support of the housing and immigrant-protection measures, and some bills were voted out with recorded no votes or not-voting members noted. After the suspense calendar was deemed approved, the committee opened public comment on bills not presented that day, heard a long list of supporters and opponents on various measures, and then adjourned.
FL
Florida 2025 Regular Session
Appropriations Committee on Pre-K - 12 Education Apr 15th, 2025
FL
Florida 2025 Regular Session
Criminal Justice Apr 1st, 2025
FL
Transcript Highlights:
- So this unregulated, non-FDA-approved intoxicating THC products that are synthesized from hemp and are
Summary:
The Committee on Fiscal Policy considered several bills and reported all of them favorably. SB 70-24, on state planning and budgeting, was presented as a modernization of the long-range planning program to simplify reporting, remove outdated measures, and focus on key data points and outcomes; it passed without opposition. CS/SB 166, on administrative efficiency in public schools, made broad changes to school accountability and operations, including lowering the stakes of certain student assessments, giving districts more flexibility on evaluations, contracts, certification, calendars, facilities, and VPK oversight. Two amendments were adopted: one clarifying that Title I funds may be used for STEM services, and another refining how advanced degrees count on salary schedules. The bill passed favorably after testimony both supporting and opposing the changes, with supporters emphasizing flexibility and opponents raising concerns about teacher evaluation and instructional practice.
CS/SB 164, on vessel accountability, was described as a measure to address derelict and at-risk vessels by improving owner identification, creating a free long-term anchoring permit program, increasing penalties, and authorizing grants for local governments in the FWC prevention program. It received support from marine industry groups and was reported favorably. CS/SB 472, on education and correctional facilities for licensed professions, would allow inmates to receive credit toward licensure for qualifying coursework; a strike-all amendment added coordination with DBPR and professional boards. The bill drew support from criminal justice, business, and policy groups and passed unanimously.
The committee spent the most time on CS/SB 438, on food and hemp products. Senator Burton and co-sponsor Senator Davis argued the bill was needed to regulate intoxicating hemp products, restrict child-appealing packaging and signage, ban synthetic hemp products, cap THC content in edibles and beverages, and require hemp beverages to be sold through alcohol-style distribution channels. Supporters, including alcohol distributors and some public safety advocates, said the bill would improve testing, labeling, and consumer protection. Opponents, including hemp retailers, farmers, and libertarian advocates, argued it would harm small businesses, reduce consumer choice, and push sales to the black market. After extensive debate, the bill was reported favorably. At the end of the meeting, senators requested to be recorded as voting in the affirmative on tab five, and the committee adjourned.
US
US Federal 2025-2026 Regular Session
Hearings to examine worldwide threats; to be immediately followed by a closed hearing in SH-219. Mar 25th, 2025 at 09:00 am
Intelligence (Select) Committee
Transcript Highlights:
- In 2023, for example, China had five first-in-class domestic drug approvals and three FDA approvals.
Keywords:
national security, cyber threats, civil liberties, transnational crime, FISA Section 702, public-private partnership, intelligence community, Annual Threats Hearing
Summary:
The Senate Intelligence Committee convened for a significant meeting focused on the Annual Worldwide Threats Hearing. Prominent officials from various intelligence agencies presented their insights on emerging national security threats, including concerns over increasing cyber threats, particularly from China and non-state actors. A major discussion point included the balance between national security and civil liberties, as evidenced by conversations surrounding Section 702 of FISA and its implications for privacy protection. The challenges posed by cartels and transnational criminal organizations, especially related to narcotics trafficking, were emphasized as pressing issues necessitating coordinated responses from federal, state, and local law enforcement agencies. This meeting underscored the necessity of public-private partnerships to tackle these multifaceted threats effectively.
TX
Transcript Highlights:
- It's supposed to, it's not FDA approved, but it's supposed to test for 75 cancers, and if that was. a
Keywords:
health impact analysis, cost analysis, coverage mandates, health insurance, legislative analysis, health care data, education, funding, classroom resources, teacher support, student outcomes, health benefits, provider dentists, payment reimbursement, insurance code, noncontracting, dental care, reimbursement, health benefit plans, noncontracting providers
FL
Florida 2025 Regular Session
Regulated Industries Mar 12th, 2025
KY
Kentucky 2025 Regular Session
House Standing Committee on Banking & Insurance (3-5-25)
Transcript Highlights:
- First, we are making clear that all FDA-approved bowel preps are fully covered by the health plan, with
Keywords:
Meeting Start: 00:00
Roll Call: 00:20
SB18 Discussion: 01:36
SB18 Vote: 05:07
SB24 Discussion: 06:37
SB24 Vote: 10:50
HB524 Discussion: 12:03
HB524 Vote: 13:55
HB421 Discussion: 15:13
HB421 Vote: 20:50
HB236 Discussion: 21:53
HB236 Vote: 23:34
HB210 Discussion: 25:40
HB210 Vote: 29:56, 958, all
Summary:
The committee met with a quorum and took up several insurance and health-related bills, beginning with Senate Bill 18, which was presented by Senator Girdler and insurance witness Adam Sheridan. The bill was described as addressing a shortage of garage liability insurance for used auto dealers in Kentucky, which has left many small dealers with only one or two coverage options and, in some cases, unable to obtain the insurance needed for a dealer license. The committee adopted a motion and second, then passed SB 18 unanimously and reported it favorably with the recommendation that it pass on the House floor.
The committee then considered Senate Bill 24, also presented by Senator Girdler with testimony from Eric DeCampo of the National Insurance Crime Bureau. The bill was framed as an anti-fraud measure that would expand the definition of a fraudulent insurance act to cover misrepresentations about property damage and repair costs in property insurance claims. Testimony emphasized that insurance fraud raises premiums for consumers and that the bill would help deter inflated or fabricated claims. After a brief question about whether the bill created new felonies, the committee voted to pass SB 24 unanimously and report it favorably.
House Bill 524, presented by Rep. Aaron Thompson with officials from the Office of the Controller and State Risk, would extend reinsurance requirements for the state’s fire and tornado/self-insurance fund from July 1 of this year to July 1, 2030, and rename the fund the Commonwealth’s Property and Casualty Insurance Fund. The bill was moved, seconded, and passed unanimously. House Bill 421, presented by Rep. Amy Neighbors, would require full coverage of FDA-approved bowel preps without out-of-pocket cost or prior authorization issues and update colorectal cancer screening coverage rules for high-risk patients by incorporating multisociety task force guidelines. Members discussed the bill’s personal importance and its minimal fiscal impact; it passed unanimously with a committee substitute. House Bill 236, presented by Rep. Adam Moore and Commissioner Sharon Clark, would cap annual out-of-pocket costs for epinephrine at $100. Members spoke in support, including personal remarks about the importance of access to epinephrine, and the bill passed unanimously with a favorable recommendation.
Finally, House Bill 210, presented by Rep. Michael “Sarge” Pollock and Dr. Steve Robertson of the Kentucky Dental Association, addressed dental limited benefit plans and direct payment to dentists. Members asked whether the bill also affected vision/hearing arrangements or third-party administrators; the witness said it was intended for non-ERISA dental plans in Kentucky and suggested follow-up with the commissioner for further clarification. The committee adopted the committee substitute and then passed HB 210 favorably, with 15 yes votes and no votes against. The meeting then adjourned, with a reminder about the Banking and Insurance dinner later that evening.
US
US Federal 2025-2026 Regular Session
Hearings to examine combating the opioid epidemic. Feb 26th, 2025 at 02:30 pm
Aging (Special) Committee
Transcript Highlights:
- learned about it goes back to actually 2010 and the reformulation of OxyContin, which was approved by the FDA
Keywords:
opioid crisis, overdose, naloxone, drug trafficking, law enforcement, treatment, prevention, older adults, Medicaid expansion
Summary:
The meeting convened to address the dire opioid crisis affecting communities nationwide, with a particular focus on the alarming rise of opioid use disorder among older adults. Key testimonies highlighted the critical need for a comprehensive approach that encompasses prevention, treatment, and strict law enforcement actions against drug traffickers. Sheriff Dennis Lima from Seminole County outlined successful strategies implemented in Florida, including increased access to naloxone and legislative changes to hold drug dealers accountable for overdoses. Various members expressed a united front on tackling this multifaceted issue, advocating for the expansion of Medicaid and better access to treatment as essential steps to curbing the epidemic.
FL
Florida 2026 Regular Session
Appropriations Committee on Health and Human Services Jan 15th, 2025
Appropriations Committee on Health and Human Services
Transcript Highlights:
- Finally, the FDA has discussed having a dentist or a chief dental officer on staff at AHCA, which there
Summary:
The Appropriations Committee on Health and Human Services heard a base budget overview for the 2025-26 fiscal year, which was presented as a $46.8 billion starting point for the silo. Staff explained that HHS accounts for about half of the state base budget and roughly 36% of general revenue, with AHCA and Medicaid making up the largest share. The committee then reviewed the PACE program for the elderly, including its eligibility, service model, growth in applications, slot funding and reversions, and the agency’s plan to move from the federal three-way agreement to a more detailed two-party contract to improve accountability, transparency, and reporting. Members raised concerns about unfilled slots, reversions, rural access, and the need for clearer return-on-investment data; the agency said it would follow up on some of those questions.
The committee also heard from the Agency for Persons with Disabilities on its statewide dental program. APD described its history of appropriations, the failed January 2024 solicitation, and a new up-to-$11.5 million solicitation focused on preventive care, community partnerships, teledentistry, and coordination with other services. Members questioned overlap with Medicaid dental coverage, the effect of Medicaid unwinding on APD clients, and whether state dollars were duplicating federally supported services; APD said it tries to act as payer of last resort and that services would continue during procurement. Public testimony from an APD stakeholder and the Florida Dental Association emphasized Medicaid eligibility problems for waiver recipients, low reimbursement rates, limited access to anesthesia and hospital-based dental care, and concerns that proposed Medicaid changes could reduce access for special-needs patients.
The Department of Veterans’ Affairs then presented on state veterans service officers and benefits assistance. FDVA highlighted its role in helping veterans access federal benefits, reporting about $27.9 billion in federal dollars flowing into Florida and a high return on state investment. The department said it has increased outreach, claims processing, and services, and has trained staff to identify mental health concerns through its Overwatch program. In response to questions, FDVA discussed plans to expand adult day health care at a new veterans nursing home and possibly at existing locations with additional state funding. At the end of the meeting, the committee completed its presentations and adjourned without objection.
FL
Florida 2025 Regular Session
Health Policy Jan 14th, 2025
NH
New Hampshire 2025 Regular Session
House Criminal Justice and Public Safety (01/23/2025)
Criminal Justice and Public Safety
Transcript Highlights:
- There are new opioid reversal agents that are currently under FDA testing that are just about ready to
- These are not coming from non-FDA-approved sources; they’re being imported.
- These are not coming from non-FDA-approved sources; they’re being imported.
- /c><05:06:13.400>
coming <05:06:13.638>from <05:06:13.840>non <05:06:14.120>FDA - <05:06:14.680>
approved are not coming from non FDA approved are not coming from non FDA approved
NH
New Hampshire 2026 Regular Session
Commission to Study Stable Tokens (03/10/2026)
Transcript Highlights:
- Really quickly, the FDA is only has right now an application for a rulemaking out for applications that's
- Really<00:32:02.640>
quickly, <00:32:03.440>uh <00:32:03.519>the <00:32:03.760>FDA - ><00:32:04.320>
is <00:32:04.559>only <00:32:04.799>has Really quickly, uh the FDA - is only has Really quickly, uh the FDA is only has right<00:32:05.200>
now <00:32:05.360>an
Summary:
The meeting began with roll call and introductions of commission members and guests, followed by approval of the agenda and a motion to approve the February 10 minutes with a correction clarifying that one quoted statement was misattributed. The commission then moved into presentations.
The main presentation came from the Conference of State Bank Supervisors on implementation of the federal GENIUS Act for stablecoins. The speaker reviewed the OCC’s recent 367-page proposed rule, noting it raises many open questions and design choices for states, and discussed expected upcoming rulemaking from the FDIC, Federal Reserve, and Treasury. The presentation focused on six areas: permissible issuer activities, reserve assets and redemption, risk management and supervision, treatment of state-qualified issuers, capital/operational backstops, and foreign issuers. It also flagged unresolved issues around Bank Secrecy Act/AML requirements and the meaning of “digital asset service provider” activities.
A substantial portion of the discussion addressed yield restrictions, with the presenter explaining the OCC’s broad definition of yield and its rebuttable presumption against issuer-affiliated or related third-party yield arrangements. The speaker said this likely forecloses many existing white-label structures but leaves some room for third-party payments depending on distance from the issuer, and noted ongoing Senate debate over similar provisions. The presentation also covered reserve valuation, liquidity and diversification requirements, redemption timing, and supervisory expectations such as third-party oversight, IT security, exam cycles, and reporting. No additional votes or formal actions were taken beyond approving the amended minutes.
NH
Transcript Highlights:
- mentioned, New Hampshire has a great opportunity to be a test case at the federal level between HHS, FDA
- mentioned, New Hampshire has a great opportunity to be a test case at the federal level between HHS, FDA
- mentioned, New Hampshire has a great opportunity to be a test case at the federal level between HHS, FDA
- mentioned, New Hampshire has a great opportunity to be a test case at the federal level between HHS, FDA
HI
Hawaii 2025 Regular Session
JHA/AGR Joint Public Hearing - Tue Feb 4, 2025 @ 2:00 PM HST
Transcript Highlights:
- Recently, the FDA told the DEA to take cannabis out of the Schedule I drug category, saying it poses
- Recently, the FDA told the DEA to take cannabis out of the Schedule I drug category, saying it poses
- Recently, the FDA told the DEA to take cannabis out of the Schedule I drug category, saying it poses
- Wendy Gibson continued: Recently, the FDA told the DEA to take cannabis out of the Schedule I drug category
Summary:
The House Committees on Judiciary and Hawaiian Affairs and Agriculture and Food Systems heard testimony and began decision-making on HB 1246, which would establish the Hawaii Cannabis and Hemp Office within DCCA to regulate cannabis. Chair Tarnas described the bill as divisive and noted the hearing had received 95 testimonies in support, 135 in opposition, and 11 comments. Members were told the office would be administratively attached to DCCA, and the department emphasized it would not direct day-to-day operations. DCCA also raised concerns about banking access due to federal law, while the Department of Agriculture supported a one-plant, one-agency approach and noted its current authority over cannabis plant importation and movement.
Several agencies and advocates supported the bill with cautions or requested amendments. The Department of Health said it appreciated the bill’s public health protections but remained concerned about increased adult-use access, youth mental health, pregnancy-related risks, and effects on developing brains; it requested a 12-month delayed effective date. The Attorney General’s office said legalization should include safeguards, recommended a longer implementation timeline and seed funding, and flagged issues in the bill involving impaired driving, open-container language, and penalties for under-21 possession. The Office of the Public Defender supported the bill but objected to new driving and possession offenses, saying existing law already covers impaired driving. Doctors for Drug Policy Reform supported the measure, citing regulation of intoxicating cannabinoids, testing, childproof packaging, and public education as public-health benefits.
Opponents focused on youth access, public safety, and the bill’s broader social effects. The Honolulu Police Department opposed the bill over access and diversion concerns, and the City and County of Honolulu Prosecutor strongly opposed legalization, citing higher-potency cannabis, youth harms, psychiatric risks, and increased poison-center calls. The Hawaiʻi Substance Abuse Coalition argued legalization should wait until prevention programs are in place and funded first, while the Hawaiʻi Family Forum and Hawaiian Republican Women also opposed the measure, citing concerns about youth exposure, added bureaucracy, and taxpayer costs. The Tax Foundation of Hawaiʻi questioned the purpose of the proposed cannabis taxes, asking why cannabis should be taxed heavily if legalization is intended. The hearing continued with additional testimony after a brief audio issue for one testifier.